List of bibliographic references
Number of relevant bibliographic references: 12.
| Ident. | Authors (with country if any) | Title |
|---|
| 000058 (2003) |
Venugopalan. Nair ; C Olanow ; Stuart. Sealfon | Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines. |
| 000089 (2005) |
C Olanow [États-Unis] ; Joseph Jankovic [États-Unis] | Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy. |
| 000129 (2007) |
Christopher. Goetz [États-Unis] ; Stanley Fahn ; Pablo Martinez ; Werner Poewe ; Cristina Sampaio ; Glenn. Stebbins ; Matthew. Stern ; Barbara. Tilley ; Richard Dodel ; Bruno Dubois ; Robert Holloway ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky ; Anthony. Lang ; Andrew Lees ; Sue Leurgans ; Peter. Lewitt ; David Nyenhuis ; C Olanow ; Olivier Rascol ; Anette Schrag ; Jeanne. Teresi ; Jacobus. Van ; Nancy Lapelle | Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. |
| 000206 (2008) |
C Olanow [États-Unis] ; Robert. Hauser ; Joseph Jankovic [États-Unis] ; William Langston ; Anthony Lang ; Werner Poewe ; Eduardo Tolosa ; Fabrizio Stocchi ; Eldad Melamed ; Eli Eyal ; Olivier Rascol | A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics. |
| 000211 (2008) |
Christopher. Goetz [États-Unis] ; Barbara. Tilley ; Stephanie. Shaftman ; Glenn. Stebbins ; Stanley Fahn ; Pablo Martinez ; Werner Poewe ; Cristina Sampaio ; Matthew. Stern ; Richard Dodel ; Bruno Dubois ; Robert Holloway ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky ; Anthony. Lang ; Andrew Lees ; Sue Leurgans ; Peter. Lewitt ; David Nyenhuis ; C Olanow ; Olivier Rascol ; Anette Schrag ; Jeanne. Teresi ; Jacobus. Van ; Nancy Lapelle | Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. |
| 000259 (2009) |
C Olanow [États-Unis] ; Olivier Rascol ; Robert Hauser ; Paul. Feigin ; Joseph Jankovic [États-Unis] ; Anthony Lang ; William Langston ; Eldad Melamed ; Werner Poewe ; Fabrizio Stocchi ; Eduardo Tolosa | A double-blind, delayed-start trial of rasagiline in Parkinson's disease. |
| 000289 (2010) |
Fabrizio Stocchi [Italie] ; Olivier Rascol ; Karl Kieburtz ; Werner Poewe ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa ; Paulo Barone ; Anthony. Lang ; C Olanow | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. |
| 000308 (2010) |
William. Marks [États-Unis] ; Raymond. Bartus ; Joao Siffert ; Charles. Davis ; Andres Lozano ; Nicholas Boulis ; Jerrold Vitek ; Mark Stacy ; Dennis Turner ; Leonard Verhagen ; Roy Bakay ; Raymond Watts ; Barton Guthrie ; Joseph Jankovic [États-Unis] ; Richard Simpson ; Michele Tagliati ; Ron Alterman ; Matthew Stern ; Gordon Baltuch ; Philip. Starr ; Paul. Larson ; Jill. Ostrem ; John Nutt ; Karl Kieburtz ; Jeffrey. Kordower ; C Olanow | Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. |
| 000327 (2011) |
Olivier Rascol [France] ; Cheryl. Fitzer ; Robert Hauser ; Joseph Jankovic [États-Unis] ; Anthony Lang ; J Langston ; Eldad Melamed ; Werner Poewe ; Fabrizio Stocchi ; Eduardo Tolosa ; Eli Eyal ; Yoni. Weiss ; C Olanow | A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. |
| 000350 (2012) |
Andrew Lees [Royaume-Uni] ; Stanley Fahn ; Karla. Eggert ; Joseph Jankovic [États-Unis] ; Anthony Lang ; Federico Micheli ; M Mouradian ; Wolfgang. Oertel ; C Olanow ; Werner Poewe ; Olivier Rascol ; Eduardo Tolosa ; David Squillacote ; Dinesh Kumar | Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. |
| 000589 (1995) |
M Mcdermott [États-Unis] ; Joseph Jankovic [États-Unis] ; J. Carter ; S. Fahn ; S. Gauthier ; C Goetz ; L Golbe ; W. Koller ; A Lang ; C Olanow | Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group. |
| 000596 (1994) |
C Olanow [États-Unis] ; S. Fahn ; M. Muenter ; H. Klawans ; H. Hurtig ; M. Stern ; I. Shoulson ; R. Kurlan ; J Grimes ; Joseph Jankovic [États-Unis] | A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "C Olanow"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i \
-Sk "C Olanow" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= JankovicV1
|flux= Ncbi
|étape= Checkpoint
|type= indexItem
|index= Author.i
|clé= C Olanow
}}
| This area was generated with Dilib version V0.6.19.
Data generation: Wed Feb 10 22:03:07 2016. Site generation: Tue Feb 13 16:14:27 2024 |  |
